NO932101D0 - Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker - Google Patents

Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker

Info

Publication number
NO932101D0
NO932101D0 NO932101A NO932101A NO932101D0 NO 932101 D0 NO932101 D0 NO 932101D0 NO 932101 A NO932101 A NO 932101A NO 932101 A NO932101 A NO 932101A NO 932101 D0 NO932101 D0 NO 932101D0
Authority
NO
Norway
Prior art keywords
humans
administered
substances
polypeptid
material used
Prior art date
Application number
NO932101A
Other languages
English (en)
Other versions
NO932101L (no
NO308396B1 (no
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO932101D0 publication Critical patent/NO932101D0/no
Publication of NO932101L publication Critical patent/NO932101L/no
Publication of NO308396B1 publication Critical patent/NO308396B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932101A 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur NO308396B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy

Publications (3)

Publication Number Publication Date
NO932101D0 true NO932101D0 (no) 1993-06-09
NO932101L NO932101L (no) 1993-08-10
NO308396B1 NO308396B1 (no) 2000-09-11

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932101A NO308396B1 (no) 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Country Status (16)

Country Link
US (1) US5824640A (no)
EP (1) EP0574394B1 (no)
JP (1) JP3213942B2 (no)
KR (1) KR100196028B1 (no)
AT (1) ATE122890T1 (no)
AU (1) AU661287B2 (no)
CA (1) CA2098113C (no)
CZ (1) CZ283037B6 (no)
DE (1) DE69110060T2 (no)
DK (1) DK0574394T3 (no)
ES (1) ES2073277T3 (no)
HU (1) HU217615B (no)
IT (1) IT1244879B (no)
NO (1) NO308396B1 (no)
RU (1) RU2113224C1 (no)
WO (1) WO1992010197A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
CA2266346A1 (en) * 1996-09-18 1998-03-26 Zetesis S.P.A. Use of proteins as agents against autoimmune diseases
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
CA2411430A1 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of parkinson's disease with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
JP2003535139A (ja) 2000-06-08 2003-11-25 レイクポール ホールディング ビー．ブイ． 哺乳動物の器官から抽出可能なタンパク質を用いる筋萎縮性側索硬化症の治療方法
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
JPH075476B2 (ja) * 1984-01-12 1995-01-25 ルッシュ、フォルケル ホルモン活性を有する生物学的作用物質、その製法およびヒストンの医薬的用途
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
RU2113224C1 (ru) 1998-06-20
AU661287B2 (en) 1995-07-20
CA2098113A1 (en) 1992-06-11
ES2073277T3 (es) 1995-08-01
DK0574394T3 (da) 1995-10-16
WO1992010197A1 (en) 1992-06-25
JP3213942B2 (ja) 2001-10-02
EP0574394B1 (en) 1995-05-24
KR100196028B1 (ko) 1999-06-15
JPH06504039A (ja) 1994-05-12
CA2098113C (en) 2002-02-05
DE69110060D1 (de) 1995-06-29
EP0574394A1 (en) 1993-12-22
AU9035791A (en) 1992-07-08
NO932101L (no) 1993-08-10
NO308396B1 (no) 2000-09-11
IT9022341A1 (it) 1992-06-11
IT1244879B (it) 1994-09-12
DE69110060T2 (de) 1995-09-28
HU217615B (hu) 2000-03-28
IT9022341A0 (it) 1990-12-11
CZ111693A3 (en) 1994-04-13
HU9301677D0 (en) 1993-09-28
HUT64569A (en) 1994-01-28
ATE122890T1 (de) 1995-06-15
CZ283037B6 (cs) 1997-12-17
US5824640A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
NO932101L (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
DE69807349D1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
DK0584266T3 (da) Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
ATE260666T1 (de) Zellulärer impfstoff und deren verwendung für die behandlung von malignen, soliden tumoren
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
ES2187568T3 (es) Vacuna viva para el tratamiento de enfermedades tumorales.
DE69635349D1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
PT951553E (pt) Proteinas de e4 de adenovirus para unducao de morte celular
ATE187493T1 (de) Gp75 als tumorimpfstoff gegen melanome
RU94045930A (ru) Белки, днк, вектор, клетка, способы получения и очистки белка, фармацевтическая композиция
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE214101T1 (de) Expression von heterologen genen in menschlichen brustzellen, einschliesslich menschliche brustkarzionomzellen unter der kontrolle von regulatorischen sequenzen von wap oder mmtv
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
EP0136093A3 (en) Anti-cancer factors
SU1077090A1 (ru) Способ получени вещества,специфически св зывающего раково-эмбриональный антиген опухолей толстого кишечника человека
DK0455769T3 (da) Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker
ATE65027T1 (de) Behandlung von parasiterkrankungen.
DE68911305D1 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.
Macher et al. Melanoma: Clinical and Therapeutic Aspects
ATE98262T1 (de) Das lungenwachstum stimulierende und hemmende faktoren fuer krebstumorzellen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees